Lih‐Ching Hsu
- Cell Biology top 5%
- Microtubule and mitosis dynamics 9
- Cancer Research top 10%
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 9
- DNA Repair Mechanisms 7
- Metabolism, Diabetes, and Cancer 7
- Cancer therapeutics and mechanisms 5
- Oncology top 10%
- Cancer-related Molecular Pathways 7
- Genetics top 10%
- BRCA gene mutations in cancer 7
-
- Cancer Mechanisms and Therapy 7
- Co-authors
- R. WhiteJih‐Hwa GuhJui‐Ling HsuJulie A. DeLoiaMichael N. GouldWei‐Ling ChangChing‐Shih ChenSusanne M. Gollin
- Partner nations
- TaiwanUnited StatesItaly
In The Last Decade
Lih‐Ching Hsu
61 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 92
- Cell Biology 308
- Cancer Research 231
- Molecular Biology 1.0k
- Oncology 371
- Genetics 263
Countries citing papers authored by Lih‐Ching Hsu
This map shows the geographic impact of Lih‐Ching Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lih‐Ching Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lih‐Ching Hsu more than expected).
Fields of papers citing papers by Lih‐Ching Hsu
This network shows the impact of papers produced by Lih‐Ching Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lih‐Ching Hsu. The network helps show where Lih‐Ching Hsu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lih‐Ching Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 9 | |
| 5 | 2023 | 3 | |
| 6 | 2019 | 37 | |
| 7 | 2018 | 14 | |
| 8 | 2017 | 23 | |
| 9 | 2016 | 8 | |
| 10 | 2016 | 7 | |
| 11 | 2015 | 42 | |
| 12 | 2014 | 25 | |
| 13 | 2013 | 20 | |
| 14 | 2012 | 17 | |
| 15 | 2012 | 19 | |
| 16 | 2008 | 22 | |
| 17 | 2007 | 42 | |
| 18 | 2006 | 35 | |
| 19 | 2004 | 3 | |
| 20 | 1991 | 5 |
About Lih‐Ching Hsu
Lih‐Ching Hsu is a scholar working on Oncology, Molecular Biology and Toxicology, having authored 62 papers that have together received 1.4k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (9 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), DNA Repair Mechanisms (7 papers), BRCA gene mutations in cancer (7 papers), Cancer-related Molecular Pathways (7 papers), Metabolism, Diabetes, and Cancer (7 papers), Cancer Mechanisms and Therapy (7 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Cell Biology (308 citations), Cancer Research (231 citations) and Molecular Biology (1.0k citations). Lih‐Ching Hsu has collaborated with scholars based in Taiwan, United States and Italy. Frequent co-authors include R. White, Jih‐Hwa Guh, Jui‐Ling Hsu, Julie A. DeLoia, Michael N. Gould, Wei‐Ling Chang, Ching‐Shih Chen, Susanne M. Gollin, Yunn‐Fang Ho and Xin Huang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.